UAB Cardiovascular Research Biobank (CARBON)
The UAB Cardiovascular Research Biobank (CARBON) is collecting biological samples, like DNA, and health information from many people over time. This resource will help researchers study heart and metabolic diseases (like diabetes and high blood pressure). They want to understand how genes, especially those related to natriuretic peptides (hormones that help regulate blood pressure and fluid balance), affect these conditions. Researchers hope to find new ways to detect, treat, or prevent diseases and understand why treatments might work differently for various individuals. This study is currently not recruiting, but aims to enroll 500 participants. You may be able to join if you are 18 years or older and not pregnant or an employee/student of the UAB Cardiovascular Disease Division.
- Study design
- This is an observational study aiming to enroll 500 participants. It is not testing a specific intervention or drug.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Genetic variants are measured at baseline, but the duration of follow-up is not specified.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
CARBON: UAB Cardiovascular Research Biobank
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Pankaj Arora, MD, FAHA · PRINCIPAL_INVESTIGATOR · University of Alabama at Birmingham
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Genetic Variants in the NPPA and NPPB gene of the Natriuretic Peptide family associated with the Cardiovascular and Metabolic DiseasesBaseline